Abstract

Despite advances of neuroimaging and clinical applications, a critical explanatory gap lies in understanding mechanisms by which synaptic-level perturbations may yield systems-level neuroimaging biomarkers. Another challenge is to understand individual variation in neuroimaging markers, to inform patient heterogeneity within and across diagnostic categories. One promising approach is to leverage biophysically-based computational models of large-scale brain dynamics, integrated with clinical and pharmacological neuroimaging.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call